AwesomeCapital
Search This Blog
Wednesday, February 26, 2020
Eidos Therapeutics EPS misses by $0.02
Eidos Therapeutics (NASDAQ:
EIDX
): Q4 GAAP EPS of -$0.51
misses by $0.02
.
Cash and cash equivalents totaled $191.2M
Press Release
https://seekingalpha.com/news/3546169-eidos-therapeutics-eps-misses-0_02
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.